Parabolic Drugs Limited (PDL), a company engaged in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates, is coming up with an Initial Public Offer (IPO) which opens for subscription from Monday, June 14, 2010
Parabolic Drugs Limited (PDL) has obtained the US FDA approval for supplying 6-APA to US markets. Book Running Lead Managers to the Issue are ICICI Securities Ltd., Spa Merchant Bankers Ltd., while Link Intime India Pvt. Ltd. is the Registrar to the Issue. The IPO would remain open for subscription till Thursday, June 17, 2010
Stay tuned to Indian IPO Blog for the latest updates on Parabolic Drugs Parabolic Drugs Limited (PDL) IPO!
Share this post on: Facebook or
Email this post to a Friend: Parabolic Drugs IPO opens from June 14, 2010